Andrew M South1,2, Patricia A Nixon1,3, Mark C Chappell2,4, Debra I Diz2,4, Gregory B Russell5, Beverly M Snively5, Hossam A Shaltout2,6, James C Rose6, T Michael O'Shea2,7, Lisa K Washburn1,2. 1. Department of Pediatrics, Wake Forest School of Medicine, Winston Salem, North Carolina. 2. Hypertension and Vascular Research Center, Wake Forest School of Medicine, Winston Salem, North Carolina. 3. Department of Health and Exercise Science, Wake Forest University, Winston Salem, North Carolina. 4. Department of Surgery, Wake Forest School of Medicine, Winston Salem, North Carolina. 5. Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston Salem, North Carolina. 6. Department of Obstetrics and Gynecology, Wake Forest School of Medicine, Winston Salem, North Carolina. 7. Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Abstract
BACKGROUND: Antenatal corticosteroid (ANCS) treatment hastens fetal lung maturity and improves survival of premature infants, but the long-term effects of ANCS are not well-described. Animal models suggest that ANCS increases the risk of cardiovascular disease through programmed changes in the renin-angiotensin (Ang)-aldosterone system (RAAS). We hypothesized that ANCS exposure alters the RAAS in adolescents born prematurely. METHODS: A cohort of 173 adolescents born prematurely was evaluated, of whom 92 were exposed to ANCS. We measured plasma and urine Ang II and Ang-(1-7) and calculated Ang II/Ang-(1-7) ratios. We used general linear regression models to estimate the difference in the RAAS between the ANCS-exposed and unexposed groups, adjusting for confounding variables. RESULTS: In unadjusted analyses, and after adjustment for sex, race, and maternal hypertension, ANCS exposure was associated with increased urinary Ang II/Ang-(1-7) (estimate 0.27 (95% CI 0.03, 0.5), P = 0.03), increased plasma Ang-(1-7) (0.66 (0.26, 1.07), P = 0.002), and decreased plasma Ang II/Ang-(1-7) (-0.48 (-0.91, -0.06), P = 0.03). CONCLUSION: These alterations indicate an imbalance in the urinary RAAS, promoting the actions of Ang II at the expense of Ang-(1-7), which over time may increase the risk of renal inflammation and fibrosis and ultimately hypertension and renal disease.
BACKGROUND: Antenatal corticosteroid (ANCS) treatment hastens fetal lung maturity and improves survival of premature infants, but the long-term effects of ANCS are not well-described. Animal models suggest that ANCS increases the risk of cardiovascular disease through programmed changes in the renin-angiotensin (Ang)-aldosterone system (RAAS). We hypothesized that ANCS exposure alters the RAAS in adolescents born prematurely. METHODS: A cohort of 173 adolescents born prematurely was evaluated, of whom 92 were exposed to ANCS. We measured plasma and urine Ang II and Ang-(1-7) and calculated Ang II/Ang-(1-7) ratios. We used general linear regression models to estimate the difference in the RAAS between the ANCS-exposed and unexposed groups, adjusting for confounding variables. RESULTS: In unadjusted analyses, and after adjustment for sex, race, and maternal hypertension, ANCS exposure was associated with increased urinary Ang II/Ang-(1-7) (estimate 0.27 (95% CI 0.03, 0.5), P = 0.03), increased plasma Ang-(1-7) (0.66 (0.26, 1.07), P = 0.002), and decreased plasma Ang II/Ang-(1-7) (-0.48 (-0.91, -0.06), P = 0.03). CONCLUSION: These alterations indicate an imbalance in the urinary RAAS, promoting the actions of Ang II at the expense of Ang-(1-7), which over time may increase the risk of renal inflammation and fibrosis and ultimately hypertension and renal disease.
Authors: Stuart R Dalziel; Natalie K Walker; Varsha Parag; Colin Mantell; Harold H Rea; Anthony Rodgers; Jane E Harding Journal: Lancet Date: 2005 May 28-Jun 3 Impact factor: 79.321
Authors: Jianli Bi; Stephen A Contag; Luke C Carey; Lijun Tang; Nancy K Valego; Mark C Chappell; James C Rose Journal: J Renin Angiotensin Aldosterone Syst Date: 2012-11-16 Impact factor: 1.636
Authors: Andrew M South; Hossam A Shaltout; Lisa K Washburn; Alexa S Hendricks; Debra I Diz; Mark C Chappell Journal: Clin Sci (Lond) Date: 2019-01-08 Impact factor: 6.124
Authors: Andrew M South; Patricia A Nixon; Mark C Chappell; Debra I Diz; Gregory B Russell; Hossam A Shaltout; T Michael O'Shea; Lisa K Washburn Journal: J Pediatr Date: 2018-11-05 Impact factor: 4.406
Authors: Alexa S Hendricks; Matthew J Lawson; Jorge P Figueroa; Mark C Chappell; Debra I Diz; Hossam A Shaltout Journal: Am J Physiol Heart Circ Physiol Date: 2019-04-05 Impact factor: 4.733
Authors: Andrew M South; Patricia A Nixon; Mark C Chappell; Debra I Diz; Gregory B Russell; Elizabeth T Jensen; Hossam A Shaltout; T Michael OʼShea; Lisa K Washburn Journal: J Hypertens Date: 2018-10 Impact factor: 4.844
Authors: Patricia A Nixon; Hossam A Shaltout; Andrew M South; Elizabeth T Jensen; T Michael O'Shea; Callie L Brown; Lisa K Washburn Journal: J Pediatr Date: 2019-10-08 Impact factor: 4.406
Authors: Andrew M South; Hossam A Shaltout; TanYa M Gwathmey; Elizabeth T Jensen; Patricia A Nixon; Debra I Diz; Mark C Chappell; Lisa K Washburn Journal: J Clin Hypertens (Greenwich) Date: 2020-05-31 Impact factor: 3.738
Authors: Lisa K Washburn; Patricia A Nixon; Beverly M Snively; Gregory B Russell; Hossam A Shaltout; Andrew M South; T Michael O'Shea Journal: Pediatr Res Date: 2017-06-21 Impact factor: 3.756